We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+3.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.13B
AUM Growth
+$508M
Cap. Flow
+$450M
Cap. Flow %
10.89%
Top 10 Hldgs %
28.06%
Holding
5,776
New
587
Increased
2,247
Reduced
2,253
Closed
660

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$135M
2
MSFT icon
Microsoft
MSFT
+$75.2M
3
NVDA icon
NVIDIA
NVDA
+$68.1M
4
AMZN icon
Amazon
AMZN
+$62.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$58.9M

Sector Composition

Rank Sector Weight
1 Technology 29.75%
2 Communication Services 9.71%
3 Consumer Discretionary 9.03%
4 Financials 8.48%
5 Healthcare 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOA
3326
BioAge Labs
BIOA
$481M
$14.9K ﹤0.01%
1,124
-1,471
-57% -$13K
EQBK icon
3327
Equity Bancshares
EQBK
$1.06B
$14.9K ﹤0.01%
333
-326
-49% -$13.9K
LFST icon
3328
Lifestance Health
LFST
$4.67B
$14.9K ﹤0.01%
2,110
-2,773
-57% -$16.7K
METCB icon
3329
Ramaco Resources Class B
METCB
$416M
$14.8K ﹤0.01%
1,296
+844
+187% +$11.5K
ABVX
3330
Abivax
ABVX
$10.6B
$14.8K ﹤0.01%
110
+67
+156% +$7.31K
PACB icon
3331
Pacific Biosciences
PACB
$357M
$14.8K ﹤0.01%
7,932
-82,983
-91% -$159K
GRND icon
3332
Grindr
GRND
$2.76B
$14.8K ﹤0.01%
1,095
-1,761
-62% -$23.9K
RCKT icon
3333
Rocket Pharmaceuticals
RCKT
$367M
$14.8K ﹤0.01%
4,219
-5,387
-56% -$18.4K
CEF icon
3334
Sprott Physical Gold and Silver Trust
CEF
$8.32B
$14.8K ﹤0.01%
+323
New +$13.1K
HIFS icon
3335
Hingham Institution for Saving
HIFS
$689M
$14.8K ﹤0.01%
52
-59
-53% -$16.9K
AOSL icon
3336
Alpha and Omega Semiconductor
AOSL
$916M
$14.8K ﹤0.01%
745
-2,304
-76% -$54.4K
BFS
3337
Saul Centers
BFS
$850M
$14.7K ﹤0.01%
467
-254
-35% -$7.8K
CGNT icon
3338
Cognyte Software
CGNT
$675M
$14.7K ﹤0.01%
1,566
-1,475
-49% -$12.8K
SSP icon
3339
E.W. Scripps
SSP
$310M
$14.7K ﹤0.01%
3,679
-1,794
-33% -$6.04K
FSBC icon
3340
Five Star Bancorp
FSBC
$1.16B
$14.7K ﹤0.01%
410
-292
-42% -$10.1K
GYRE icon
3341
Gyre Therapeutics
GYRE
$706M
$14.7K ﹤0.01%
2,077
-617
-23% -$4.76K
CYPH
3342
Cypherpunk Technologies Inc
CYPH
$69.8M
$14.6K ﹤0.01%
+12,605
New +$13.8K
IVR icon
3343
Invesco Mortgage Capital
IVR
$805M
$14.6K ﹤0.01%
1,737
-6,990
-80% -$54.8K
VBNK
3344
VersaBank
VBNK
$628M
$14.6K ﹤0.01%
974
+973
+97,300% +$12.3K
NVTS icon
3345
Navitas Semiconductor
NVTS
$3.57B
$14.5K ﹤0.01%
2,030
-25,897
-93% -$249K
ARQ icon
3346
Arq
ARQ
$100M
$14.5K ﹤0.01%
4,430
+2,198
+98% +$10.7K
RBRK icon
3347
Rubrik
RBRK
$21.6B
$14.5K ﹤0.01%
189
-4,006
-95% -$307K
SMTI icon
3348
Sanara MedTech
SMTI
$316M
$14.5K ﹤0.01%
619
+252
+69% +$6.51K
GTLB icon
3349
GitLab
GTLB
$7.32B
$14.4K ﹤0.01%
385
-18,353
-98% -$794K
CYRX icon
3350
CryoPort
CYRX
$766M
$14.4K ﹤0.01%
1,505
-168
-10% -$1.59K

Similar funds

Tower Research Capital (TRC)'s Q4 2025 Portfolio in Review

As of Q4 2025, Tower Research Capital (TRC) held 5,776 positions worth $4.13B, up 14% from $3.62B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Tower Research Capital (TRC) deployed $450M of net new capital in Q4 2025, opening 587 new positions and adding to 2,247 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 139,132 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 17% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $431M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2025 buy was iShares 20+ Year Treasury Bond ETF: 139,132 shares worth $12.1M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2025, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $431M.
  • Tower Research Capital (TRC) fully exited iShares 0-3 Month Treasury Bond ETF in Q4 2025, selling an estimated $25.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 28% of its $4.13B portfolio in Q4 2025.
  • Tower Research Capital (TRC) opened 587 new positions and closed 660 in Q4 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 14% quarter-over-quarter to $4.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.